Please login to the form below

Not currently logged in
Email:
Password:

lubiprostone

This page shows the latest lubiprostone news and features for those working in and with pharma, biotech and healthcare.

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt is paying $18 per share for Sucampo and will also assume the company’s $360m debt under the terms of the deal, adding Amitizia (lubiprostone), glaucoma treatment Rescula (unoprostone isopropyl)

Latest news

  • Lilly’s Efient and Sucampo's Amitiza win NICE backing Lilly’s Efient and Sucampo's Amitiza win NICE backing

    NICE, which provides healthcare recommendations to the NHS, issued new guidance on the use of Sucampo Pharma Europe's Amitiza (lubiprostone) for adults with chronic idiopathic constipation and updated its view

  • NICE backs constipation treatment NICE backs constipation treatment

    Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance. ... For many of the patients who are refractory to standard laxatives, effectively treating with lubiprostone in primary care

  • NICE backs constipation treatment NICE backs constipation treatment

    Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance. ... For many of the patients who are refractory to standard laxatives, effectively treating with lubiprostone in primary care

  • AZ drug for opioid constipation starts FDA review AZ drug for opioid constipation starts FDA review

    up to compete with Sucampo and Takeda's twice-daily Amitiza (lubiprostone).

  • Sucampo-Takeda to file for US approval of Amitiza as OBD treatment

    The response rate for lubiprostone-treated patients was 26.9 per cent compared to 18.6 per cent for the placebo group, which was a statistically significant increase. ... If approved, lubiprostone could be the first orally-administered medicine with the

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics